Scientists uncover a novel approach to treating Duchenne muscular dystrophy – EurekAlert

As Duchenne muscular dystrophy progresses, levels of a beneficial RNA (purple), called miR-206, in muscles decrease over time. In the study, the scientists were able to boost the amount of miR-206 in extracellular vesicles that are delivered to muscle stem cells, which promoted muscle repair.
CREDIT: Sanford Burnham Prebys Medical Discovery Institute

 
Scientists at Sanford Burnham Prebys Medical Discovery Institute, Fondazione Santa Lucia IRCCS, and Università Cattolica del Sacro Cuore in Rome have shown that pharmacological (drug) correction of the content of extracellular vesicles released within dystrophic muscles can restore their ability to regenerate muscle and prevent muscle scarring (fibrosis). The study, published in EMBO Reports, reveals a promising new therapeutic approach for Duchenne muscular dystrophy (DMD), an incurable muscle-wasting condition, and has far-reaching implications for the field of regenerative medicine.

Click here to read full article https://www.eurekalert.org/pub_releases/2020-09/sbpm-sua091420.php

Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Font Resize